Frazier Life Sciences Public Fund, L.P., 10% Owner at Viridian Therapeutics, Inc.\DE (VRDN), bought 200,000 shares at $11.00 ($2.2M) on 2021-09-23, disclosed to the SEC on 2021-09-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.